A Novel Modified Bu/Vp16/cy/Flu/Ara‐C Conditioning Regimen Enhances Outcomes for High‐Risk Acute Lymphoblastic Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Documenti analoghi

• A PRSZT Registry Analysis of Prognostic Factors Influencing Survival and Relapse Rates After Second Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia
  di: Ava Momm, et al.
  Pubblicazione: (2026)
• Pediatric Mixed Phenotype Acute Leukemia With ETV6 :: ARNT Fusion Gene Successfully Treated by Allogeneic Hematopoietic Stem Cell Transplantation
  di: Yaoyao Rui, et al.
  Pubblicazione: (2025)
• Venetoclax‐Based Therapy for Early Relapse in Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report and Minireview
  di: Yufeng Du, et al.
  Pubblicazione: (2025)
• Increasing Access to Pediatric Allogeneic Hematopoietic Stem Cell Transplantation in South Africa
  di: Candice Laverne Hendricks, et al.
  Pubblicazione: (2026)
• VZV Prophylaxis After Allogeneic Hematopoietic Stem Cell Transplantation in Children: When to Stop?
  di: Eva de Berranger, et al.
  Pubblicazione: (2024)